| (CAD) | Jul 2021 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -2.77M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HBP.TO returned +48.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -15.2% |
| 1 year | +48.9% |
| 5 years | -49.8% |
| 10 years | -78.5% |
| All-time high | $35.00 (Oct 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in HBP.TO would be worth today ›No. Helix BioPharma Corp. has not paid a dividend in the past 12 months.
Helix BioPharma Corp. is part of the Healthcare sector.
Helix BioPharma Corp. has a market cap of 153.52M CAD, based on the latest quote.
Helix BioPharma Corp. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
